Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cerebrospinal fluid neuroplasticity-associated protein levels in patients with psychiatric disorders: a multiplex immunoassay study
Shinsuke Hidese, Kotaro Hattori, Daimei Sasayama, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Association between vascular endothelial growth factor-mediated blood–brain barrier dysfunction and stress-induced depression
Hitomi Matsuno, Shoko Tsuchimine, Kazunori Ohashi, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 9, pp. 3822-3832
Closed Access | Times Cited: 93
Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression
M. Michel, Bernd L. Fiebich, Hanna Kuzior, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 63
Neuroinflammation and Post-Stroke Depression: Focus on the Microglia and Astrocytes
Weizhuo Lu, Jiyue Wen
Aging and Disease (2024)
Open Access | Times Cited: 15
Biomarkers in the cerebrospinal fluid of patients with psychotic disorders compared to healthy controls: a systematic review and meta-analysis
Troels Boldt Rømer, Rose Jeppesen, Rune Haubo Bojesen Christensen, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 6, pp. 2277-2290
Closed Access | Times Cited: 20
Genetic association and drug target exploration of inflammation-related proteins with risk of major depressive disorder
Wen-xi Sun, Hongbao Cao, Dongming Liu, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 136, pp. 111165-111165
Closed Access | Times Cited: 6
Astrocytes in Post-Stroke Depression: Roles in Inflammation, Neurotransmission, and Neurotrophin Signaling
Dongqing Jing, Xiaoli Hou, Xiao Guo, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 7, pp. 3301-3313
Closed Access | Times Cited: 13
Correlation between S100B and severity of depression in MDD: A meta-analysis
Ümit Tural, Molly Irvin, Dan V. Iosifescu
The World Journal of Biological Psychiatry (2021) Vol. 23, Iss. 6, pp. 456-463
Closed Access | Times Cited: 27
High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers
Ricard Navinés, Giovanni Oriolo, Igor Horrillo, et al.
The International Journal of Neuropsychopharmacology (2022) Vol. 25, Iss. 6, pp. 468-478
Open Access | Times Cited: 17
MAPPING THE CEREBROSPINAL FLUID PROTEOME IN BIPOLAR DISORDER
Andreas Göteson, Jessica Holmén‐Larsson, Hakan Hamdi Çelik, et al.
Biological Psychiatry (2025)
Open Access
Identifying novel protein biomarkers with cross-psychiatric disorders effects and potential intervention targets: Evidence from proteomic-Mendelian randomization
Ronghui Zhang, Jia Luo, Tong Wang, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025) Vol. 139, pp. 111396-111396
Closed Access
Search for cerebrospinal fluid biomarkers in patients with major psychiatric disorders: Multiplex immunoassay findings and proximity extension assay prospects
Shinsuke Hidese
Neuropsychopharmacology Reports (2024) Vol. 44, Iss. 2, pp. 314-320
Open Access | Times Cited: 3
Glial cell line-derived neurotrophic factor (GDNF) in blood serum and lacrimal fluid of patients with a current depressive episode
Mikhail Zinchuk, Alla Guekht, Т. А. Дружкова, et al.
Journal of Affective Disorders (2022) Vol. 318, pp. 409-413
Closed Access | Times Cited: 13
Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay study
Shinsuke Hidese, Fuyuko Yoshida, Ikki Ishida, et al.
Neuropsychopharmacology Reports (2022) Vol. 43, Iss. 1, pp. 57-68
Open Access | Times Cited: 13
The blood-brain barrier in bipolar disorders: A systematic review
Clara Wakonigg Alonso, Frances McElhatton, Brian O’Mahony, et al.
Journal of Affective Disorders (2024) Vol. 361, pp. 434-444
Open Access | Times Cited: 2
The therapeutic potential of traditional Chinese medicine in depression: focused on the modulation of neuroplasticity
Shimeng Lv, Ni Yang, Yitong Lu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
From inflammation to depression: key biomarkers for IBD-related major depressive disorder
Chaoqun Hu, Ming Ge, Yan Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Potential biomarkers: differentially expressed proteins of the extrinsic coagulation pathway in plasma samples from patients with depression
Chun-Yue Yu, Te-Li Zhang, Shanshan Shi, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 6318-6331
Open Access | Times Cited: 14
Alteration of NMDA receptor trafficking as a cellular hallmark of psychosis
Agnès Espana, Henrik Seth, Julie Jézéquel, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 14
Brain vasculature disturbance in schizophrenia
Sofía Puvogel, Verónica Palma, Iris E. Sommer
Current Opinion in Psychiatry (2022) Vol. 35, Iss. 3, pp. 146-156
Open Access | Times Cited: 10
Longitudinal assessment of S100B serum levels and clinical factors in youth patients with mood disorders
Aleksandra Rajewska‐Rager, Monika Dmitrzak‐Węglarz, Paweł Kapelski, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 12
Mental Illness and Amyloid: A Scoping Review of Scientific Evidence over the Last 10 Years (2011 to 2021)
Gianluca Pandolfo, Fiammetta Iannuzzo, Giovanni Genovese, et al.
Brain Sciences (2021) Vol. 11, Iss. 10, pp. 1352-1352
Open Access | Times Cited: 12
Schizophrenia and Alarmins
Huan Ma, Ning Cheng, Caiyi Zhang
Medicina (2022) Vol. 58, Iss. 6, pp. 694-694
Open Access | Times Cited: 9
Vascular-related biomarkers in psychosis: a systematic review and meta-analysis
Xiaojun Li, Shuang Hu, Pozi Liu
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 5
IL-33 in Mental Disorders
Gianluca Pandolfo, Giovanni Genovese, Marco Casciaro, et al.
Medicina (2021) Vol. 57, Iss. 4, pp. 315-315
Open Access | Times Cited: 11
The Association of Biochemical and Genetic Biomarkers in VEGF Pathway with Depression
Fernanda Daniela Dornelas Nunes, Letícia Perticarrara Ferezin, Sherliane Carla Pereira, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2757-2757
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top